Professional Documents
Culture Documents
Q.7 If the leak test falls during In-process checks, what needs to be
done?
Ans: Immediately stop the packing process and check for:
1. Sealing temperature
2. Check knurling quality and change in printed foil.
3. Check & quarantine the isolated quantity of packed goods from the last
leak test passed during in-process.
4. Collect random samples & do a retest.
5. Blisters from the leak test passed containers shall allow going further,
and the rest must be de-blistered/ Defoil accordingly.
Q.20 What checks shall be carried out during the calibration of the
Disintegration Test apparatus?
Ans: 1. Strokes number per minute. It shall be a 29-32 cycle per minute.
2. Temperature by using probes and a standard thermometer. It shall be
37±1°C
3. Traveling distance by the basket. It shall be 53-57 mm.
Q.21 Why is positive pressure kept in the corridor, not in the process
area?
Ans: The different pressure gradient is essential at different locations to
avoid cross-contamination of a product through the air.
Q.25 Tell the time required for long-term and accelerated stability
testing.
Ans: long term study 12 months
Accelerated stability for six months.
Q.42 Suppose the Area is class 100000, then what are the maximum
light and sound levels as per guidelines?
Ans: light level: not less than 300 lux.
Sound level: it should not be more than 80 decibels.
It helps to know about Impurities that develop during the storage of drug
products in various environmental conditions. Forced degradation study
depends upon the product and the type of dosage form. Solid, liquid, and
injection have different procedures for the stress study.
The specification limit for the assay is 90.0-110.0 % w/w of the label
claim.
For a selected batch, the result obtained is 85.2 % w/w – This result is
out of the specification limit, which is often called OOS.
Q.53 If the temperature or RH of the Area goes out of the limit, what
action is to be taken?
Ans: immediately stop the line, and inform the responsible department to
raise the maintenance requisition slip. Ensure that all the intermediate
materials are correctly covered.
Q.57 Tell How many batches took for the process validation?
Ans: The EMA draft guideline states “a minimum of three consecutive
batches,” with justification to be provided (there are some exceptions to
the current statement).
The USFDA guidance states that the number or quantity of batches must
be sufficient to supply statistical confidence in the method. It is a subtle
but essential distinction in the approaches.
• General information
• Objective
• Background/Pr- validation Activities, Summary of
development and tech transfer (from R&D or another Site)
activities to justify in-process testing and controls; any
Previous validations.
• List of Equipment and their qualification status
• Facilities qualification
• Process flow charts
• Manufacturing procedure narrative
• List of critical processing parameters and necessary
excipients
• Sampling, tests, and specifications
• Acceptance criteria
Q.61 What should be the blend sample size in In-process validation
studies?
Ans: It is a 1x – 3x dosage unit range on a case-to-case basis. As per
USFDA guidance, sampling sizes are often increased from lx -10x with
adequate scientific justification.
Q.63 What will be the reason for the inside location variance of blend
data?
Ans: Inadequacy of blend mix, sampling error, or agglomeration